Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Public ClinicalTrials.gov record NCT05552755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b-2, Multicenter, Trial to Evaluate the Efficacy, Safety, Pharmacokintetics, and Pharmacodynamics of REC-4881 in Patients With Familial Adenomatous Polyposis (FAP)
Study identification
- NCT ID
- NCT05552755
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Recursion Pharmaceuticals Inc.
- Industry
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- REC-4881 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 9, 2023
- Primary completion
- May 31, 2027
- Completion
- Aug 31, 2027
- Last update posted
- Apr 15, 2026
2023 – 2027
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Scottsdale | Scottsdale | Arizona | 85259 | Active, not recruiting |
| Del Sol Research Management | Tucson | Arizona | 85715 | Withdrawn |
| Medical Associates Research Group | San Diego | California | 92123 | Withdrawn |
| GI Pros | Naples | Florida | 34102 | Withdrawn |
| Digestive and Liver Center of Florida | Orlando | Florida | 32825 | Terminated |
| Gastroenterology Health Partners, PLLC | New Albany | Indiana | 47150 | Withdrawn |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | Terminated |
| Corewell Health (Spectrum Health Hospitals Colorectal Cancer Multis) | Grand Rapids | Michigan | 49503 | Recruiting |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Gastro One-8110 Walnut Rs | Cordova | Tennessee | 38108 | Terminated |
| Vanderbilt Digestive Center | Nashville | Tennessee | 37232 | Recruiting |
| Genetic Cancer Prevention Clinic - UT Southwestern | Dallas | Texas | 75390 | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Huntsman Cancer Institute and University of Utah | Salt Lake City | Utah | 84112 | Recruiting |
| Benaroya Research Institute at Virginia Mason | Seattle | Washington | 98101 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05552755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05552755 live on ClinicalTrials.gov.